The Western blot analysis showed that fucoidan treatment downregulated the expression of β-catenin and its downstream target genes, c-Myc, Cyclin D1 and Survivin, in 4T1 and tumor-bearing mice. The gene discussed is CCND1; the disease is neoplasm.